Questions about compensation after being harmed by a defective drug or medical device? Contact our law office to speak with one of our attorneys.

West Virginia Federal Jury Awards $3.27 Million Verdict against Johnson and Johnson’s Ethicon

In another victory for plaintiffs against vaginal-mesh implant manufacturers, a federal jury in West Virginia found for the plaintiff Jo Huskey and ordered Johnson & Johnson to pay $3.27 million.  Jurors found that J&J defectively designed the Ethicon TVT-O sling and failed to properly warn doctors and patients the device could erode, subsequently damaging organs [...]

September 5th, 2014|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on West Virginia Federal Jury Awards $3.27 Million Verdict against Johnson and Johnson’s Ethicon

Despite Earning $17 Billion and Paying No Taxes from 2010 through 2012, Pfizer Seeks to Renounce American Citizenship for Tax Benefits

Founded in a red brick building in Brooklyn in 1849, Pfizer, one of America’s oldest companies and the seller of the hugely profitable Viagra and Lipitor, is seeking to renounce its American citizenship and move to climes where it can pay fewer taxes. Despite its huge success in the US with its powerhouse blockbusters bringing [...]

May 21st, 2014|Drug and Medical Device Litigation, Lipitor|Comments Off on Despite Earning $17 Billion and Paying No Taxes from 2010 through 2012, Pfizer Seeks to Renounce American Citizenship for Tax Benefits

Due to Numerous Injuries, FDA Proposes Reclassifying Vaginal Mesh Devices from Class 2 to Class 3

Based on a number of risks associated with the transvaginal mesh devices including infection, vaginal bleeding, damage to connective tissues, nerves, and blood vessels, on May 1, 2014, the FDA proposed reclassification of mesh devices from Class 2 to the more rigorous Class 3 status. "The FDA has identified clear risks associated with surgical mesh [...]

May 5th, 2014|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on Due to Numerous Injuries, FDA Proposes Reclassifying Vaginal Mesh Devices from Class 2 to Class 3

FDA Issues Warning Letter to Mesh Manufacturer ENDO for Federal Regulation Violations

Endo International PLC, a subsidiary of American Medical Systems, Inc. was recently issued a warning letter by the FDA for violating three federal regulations relating to how the Minnesota company facility manufactures its urological devices. Click here to read the full article: Inspection Triggers FDA Warning for Mesh Manufacturer While the warnings does not pertain [...]

April 25th, 2014|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on FDA Issues Warning Letter to Mesh Manufacturer ENDO for Federal Regulation Violations

Five Boston Scientific Mesh Cases Remanded for Trial in Florida

On April 11, 2014, Judge Joseph Goodwin consolidated five Boston Scientific mesh cases and set them for trial on September 29, 2014 in Southern District of Florida. The cases are: Eghnayem v. Boston Scientific Corporation, 2:13-cv-07965 Dotres v. Boston Scientific Corporation, 2:13-cv-10077 Nunez v. Boston Scientific Corporation, 2:13-cv-24346 Dubois-Jean v. Boston Scientific Corporation, 2:14-cv-04455, and [...]

April 14th, 2014|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on Five Boston Scientific Mesh Cases Remanded for Trial in Florida

Dallas Jury Awards $1.2 Million Verdict Against Johnson and Johnson’s Ethicon

In another victory for plaintiffs against vaginal-mesh implant manufacturers, a Dallas jury found for the plaintiff Linda Batiste and ordered Johnson & Johnson to pay $1.2 million in compensatory damages.  The jury declined to award punitive damages. (Batiste v. McNabb, No. 12-14350, District Court for the 95th Judicial District, Dallas County Texas (Dallas)). The jury [...]

April 9th, 2014|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on Dallas Jury Awards $1.2 Million Verdict Against Johnson and Johnson’s Ethicon

Takeda Held Responsible in First Federal Actos Bellwether Trial

After 34 days of trial, a Lafayette, Louisiana jury returned its verdict against Takeda and Lilly and ordered the PHARMA giants to pay $1.475 million in compensatory damages and $8 billion in punitive damages for injuries including bladder cancer to Terrance Allen, a hardware store manager, who took Actos for his diabetes treatment from 2004 [...]

April 8th, 2014|Actos Diabetes Drug, Drug and Medical Device Litigation|Comments Off on Takeda Held Responsible in First Federal Actos Bellwether Trial

Court Sets Key Dates Leading to Trial in Boston Scientific Vaginal Mesh Cases

Judge Joseph Goodwin set the following key dates for the run up to trial in the vaginal mesh cases vs Boston Scientific currently set for October 14, 2014. Pretrial Order 87 provides as follows: Plaintiffs shall serve expert reports by 5/11/2014 and provide proposed deposition dates to occur by 7/1/2014; Defendants shall serve expert reports [...]

April 7th, 2014|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on Court Sets Key Dates Leading to Trial in Boston Scientific Vaginal Mesh Cases

J&J and the Destroyed Records in Vaginal Mesh Cases

On February 4, 2014, Federal Magistrate Judge Cheryl Eifert found that Johnson and Johnson lost or destroyed thousands of documents and computer files dating back to 2007 related to development of J&J’s Gynecare Prolift and TVT Retropubic meshes. At the time, current J&J CEO Alex Gorsky was the head of the Ethicon Subsidiary responsible for [...]

March 28th, 2014|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on J&J and the Destroyed Records in Vaginal Mesh Cases

Teva Agrees to Pay $27.6 Million to Resolve Clozapine Doctor Kickback Allegations

TEVA (Teva Pharmaceutical Industries Limited) has agreed to pay the State of Illinois and the U.S. Department of Justice $27.6 Million for violating the U.S. False Claims Act.  Units of Teva Pharmaceutical violated the Act by eliciting Dr. Michael Reinstein, an Illinois physician, to prescribe Clozapine, an anti-schizophrenia drug, to patients in federal programs such [...]

March 14th, 2014|Drug and Medical Device Litigation|Comments Off on Teva Agrees to Pay $27.6 Million to Resolve Clozapine Doctor Kickback Allegations